I Kuss
Overview
Explore the profile of I Kuss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jonat W, Bachelot T, Ruhstaller T, Kuss I, Reimann U, Robertson J
Ann Oncol
. 2013 Jun;
24(10):2543-2548.
PMID: 23788750
Background: The progesterone-receptor (PR) antagonists onapristone (type I) and mifepristone (type II) showed modest activity in hormone-receptor-positive breast cancer; however, onapristone in particular was associated with hepatotoxicity. Lonaprisan is a...
2.
Kuss I, Hathaway B, Ferris R, Gooding W, Whiteside T
Adv Otorhinolaryngol
. 2004 Dec;
62:161-72.
PMID: 15608426
Apoptosis of circulating CD8+T cells seen in patients with squamous cell carcinoma of the head and neck (HNSCC) suggests a possibility of lymphocyte imbalance. Therefore, absolute numbers and percentages of...
3.
Bauernhofer T, Eibl M, Ploner F, Kuss I, Pfeifer J, Sill H, et al.
Onkologie
. 2003 Sep;
26(4):344-6.
PMID: 12972700
Background: Acute intestinal pseudo-obstruction is a potentially life-threatening disease which is characterized by massive dilation of the colon or small intestine without mechanical obstruction and may develop after surgery or...
4.
Bauernhofer T, Kuss I, Friebe-Hoffmann U, Baum A, Dworacki G, Vonderhaar B, et al.
Br J Cancer
. 2003 Apr;
88(8):1301-9.
PMID: 12698200
Prolactin (PRL) has been reported to inhibit apoptosis in various cell types and to serve as a cofactor in the upregulation of CD25 on T cells during activation. We investigated...
5.
Kuss I, Donnenberg A, Gooding W, Whiteside T
Br J Cancer
. 2003 Mar;
88(2):223-30.
PMID: 12610507
A subset of circulating T cells (CD8(+)CD45RO(-)CD27(-)) with a naïve phenotype, but mediating effector function, is considered to play an important role in host antitumour defence. To investigate the attributes...
6.
Dworacki G, Meidenbauer N, Kuss I, Hoffmann T, Gooding W, Lotze M, et al.
Clin Cancer Res
. 2001 Apr;
7(3 Suppl):947s-957s.
PMID: 11300496
Expression of T-cell receptor- or Fcgamma receptor III-associated signal-transducing zeta chain is important for the functional integrity of immune cells. We found that significantly higher proportions of circulating CD3+ T...
7.
Bauernhofer T, Stoger H, Kasparek A, Ploner F, Kuss I, Pieber T, et al.
Oncology
. 1999 Nov;
57(4):265-8.
PMID: 10575309
We report on a 28-year-old male with a single metastasis of an osteosarcoma in the twelfth thoracic vertebra occurring 9 years after initial diagnosis of the primary tumour in the...
8.
Samonigg H, Wilders-Truschnig M, Kuss I, Plot R, Stoger H, Schmid M, et al.
J Immunother
. 1999 Nov;
22(6):481-8.
PMID: 10570746
This article reports on the first double-blind randomized clinical study with an antiidiotype antibody vaccine in patients with metastatic colorectal carcinoma. The study was performed to determine immunological parameters, efficacy,...
9.
Saito T, Kuss I, Dworacki G, Gooding W, Johnson J, Whiteside T
Clin Cancer Res
. 1999 Jul;
5(6):1263-73.
PMID: 10389908
Proportions of apoptotic (TUNEL+) peripheral blood mononuclear cells (PBMCs) were measured by flow cytometry in patients with head and neck cancer and normal controls at the time of blood draws...
10.
Kuss I, Saito T, Johnson J, Whiteside T
Clin Cancer Res
. 1999 Feb;
5(2):329-34.
PMID: 10037182
Patients with squamous cell carcinoma of the head and neck (SCCHN) frequently have impaired immune responses. Alterations in T-cell receptor-associated signaling molecules in tumor-infiltrating as well as circulating lymphocytes have...